Barclays
ERNA icon

Barclays’s Eterna Therapeutics ERNA Stock Holding History

Barclays’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Hold
0
– -$1K – 7037
2018
Q3 		– Hold
0
– – – 7014
2018
Q2 		– Hold
0
– – – 7039
2018
Q1 		– Hold
0
– – – 7127
2017
Q4 		– Hold
0
– – – 6835
2017
Q3 		– Hold
0
– – – 6751
2017
Q2 		– Hold
0
– – – 6501
2017
Q1 		– Hold
0
– – – 6573
2016
Q4 		– Hold
0
– – – 6450
2016
Q3 		– Hold
0
– – – 6383
2016
Q2 		– Hold
0
– – – 6385
2016
Q1 		– Hold
0
– – – 6216
2015
Q4 		– Hold
0
– – – 6121

Other funds holding ERNA

North Star Investment Management
North Star Investment Management Chicago, Illinois $1.85B AUM 21.53% 1-Year Est. Return
Bard Associates
Bard Associates Chicago, Illinois $431M AUM 30.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Callahan Advisors
Callahan Advisors Houston, Texas $1.32B AUM 23.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return